Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group-Reference-Cited by-同舟云学术

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

Published:2013-11-21 Issue:2 Volume:89 Page:145-150
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Katodritou Eirini¹,Terpos Evangelos²,Kelaidi Charikleia³,Kotsopoulou Maria⁴,Delimpasi Sossana⁵,Kyrtsonis Marie-Christine⁶,Symeonidis Argiris⁷,Giannakoulas Nikos⁸,Stefanoudaki Aikaterini⁹,Christoulas Dimitrios¹⁰,Chatziaggelidou Christina¹,Gastari Vassiliki¹,Spyridis Nikos¹,Verrou Evgenia¹,Konstantinidou Pavlina¹,Zervas Kostas¹,Dimopoulos Meletios A.²

Affiliation:

1. Hematology Department; Theagenion Cancer Hospital; Thessaloniki Greece

2. Department of Clinical Therapeutics; National and Kapodistrian University of Athens, School of Medicine; Athens Greece

3. Hematology Department; General Hospital “G. Papanikolaou,”; Thessaloniki Greece

4. Hematology Department; General Anticancer Hospital “Metaxa,”; Athens Greece

5. Hematology Department; General Hospital of Athens “Evangelismos,”; Athens Greece

6. First Department of Propedeutic/Internal Medicine; National and Kapodistrian University of Athens, School of Medicine; Athens Greece

7. Hematology Division; University of Patras Medical School; Patras Greece

8. Hematology Department; University of Thessalia; School of Medicine; Larissa Greece

9. Hematology Department; General Hospital of Athens “Amalia Fleming,”; Athens Greece

10. Department of Hematology; 251 General Air-Force Hospital; Athens Greece

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23600/fullpdf

Reference28 articles.

1. Plasma cell leukemia: An evaluation of response to therapy;Noel;Am J Med,1987

2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group;International Myeloma Working Group;Br J Haematol,2003

3. Genetic aberrations and survival in plasma cell leukemia;Tiedemann;Leukemia,2008

4. Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics;Garcia-Sanz;Blood,1999

5. Cytogenetics, interphase and multicolor fluorescence in situ hybrodization analyses in primary plasma cell leukemia: A study of 40 patients at diagnosis, on behalf of the Intergroup Francophone du Myelome and the Group Francais de Cytogenetique Hematologique;Avet-Loiseau;Blood,2001

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia;Cancer Medicine;2024-09

2. Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States;Leukemia;2023-12-04

3. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study;Hematology;2023-09-21

4. Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group;American Journal of Hematology;2023-03-16

5. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-03